Form 4: Phillip Frost Increases Stake in OPKO Health with $500,000 Purchase
SEC Form 4 Filing
Phillip Frost, CEO and Chairman of OPKO Health, acquires 500,000 shares of common stock at an average price of $0.9923.
Summary
- Phillip Frost, CEO and Chairman of OPKO Health, along with Frost Gamma Investments Trust, filed a Form 4 with the SEC.
- On February 28, 2024, Frost purchased 500,000 shares of OPKO Health common stock at a weighted average price of $0.9923 per share, with prices ranging from $0.9772 to $1.01.
- Following the transaction, Frost directly owns 3,068,951 shares and indirectly owns 208,868,225 shares through Frost Gamma Investments Trust and 30,127,177 shares through Frost Nevada Investments Trust.
- Frost disclaims beneficial ownership of the indirectly held securities except to the extent of any pecuniary interest.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a report of insider buying, which can be interpreted positively, but it's a single transaction and doesn't provide a comprehensive view of the company's performance.
Positives
- The CEO's purchase of a significant number of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company believe its stock is undervalued.
Stakeholder Impact
- The increased stake by the CEO could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of the transaction: Phillip Frost purchased 500,000 shares of OPKO Health common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.